Skip to main content
Thorax logoLink to Thorax
. 1982 Nov;37(11):834–839. doi: 10.1136/thx.37.11.834

Endogenous opiates and the control of breathing in normal subjects and patients with chronic airflow obstruction.

M V Tabona, N Ambrosino, P J Barnes
PMCID: PMC459436  PMID: 7164001

Abstract

To investigate the role of endorphins in central respiratory control, the effect of naloxone, a specific opiate antagonist, on resting ventilation and ventilatory control was investigated in a randomised double-blind, placebo-controlled study of normal subjects and patients with chronic airways obstruction and mild hypercapnia due to longstanding chronic bronchitis. In 13 normal subjects the ventilatory response to hypercapnia increased after an intravenous injection of naloxone (0.1 mg/kg), ventilation (VE) at a PCO2 of 8.5 kPa increasing from 55.6 +/- SEM 6.2 to 75.9 +/- 8.21 min-1 (p less than 0.001) and the delta VE/delta PCO2 slope increasing from 28.6 +/- 4.4 to 34.2 +/- 4.21 min-1 kPa-1 (p less than 0.05). There was no significant change after placebo (saline) injection. Naloxone had no effect on resting ventilation or on the ventilatory response to hypoxia in normal subjects. In all six patients naloxone significantly (p less than 0.02) increased mouth occlusion pressure (P 0.1) responses to hypercapnia. Although there was no change in resting respiratory frequency or tidal volume patients showed a significant (p less than 0.01) decrease in inspiratory timing (Ti/Ttot) and increase in mean inspiratory flow (VT/Ti) after naloxone. These results indicate that endorphins have a modulatory role in the central respiratory response to hypercapnia in both normal subjects and patients with airways obstruction. In addition, they have an inhibitory effect on the control of tidal breathing in patients with chronic bronchitis.

Full text

PDF
834

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adler M. W. Opioid peptides. Life Sci. 1980 Feb 18;26(7):497–510. doi: 10.1016/0024-3205(80)90312-4. [DOI] [PubMed] [Google Scholar]
  2. Akil H., Mayer D. J., Liebeskind J. C. Antagonism of stimulation-produced analgesia by naloxone, a narcotic antagonist. Science. 1976 Mar 5;191(4230):961–962. doi: 10.1126/science.1251210. [DOI] [PubMed] [Google Scholar]
  3. Atweh S. F., Kuhar M. J. Autoradiographic localization of opiate receptors in rat brain. II. The brain stem. Brain Res. 1977 Jun 24;129(1):1–12. doi: 10.1016/0006-8993(77)90965-9. [DOI] [PubMed] [Google Scholar]
  4. Berger A. J., Mitchell R. A., Severinghaus J. W. Regulation of respiration (first of three parts). N Engl J Med. 1977 Jul 14;297(2):92–97. doi: 10.1056/NEJM197707142970206. [DOI] [PubMed] [Google Scholar]
  5. Cameron I. R. The investigation of the respiratory response to hypercapnia. Bull Eur Physiopathol Respir. 1979;15 (Suppl):213–221. [PubMed] [Google Scholar]
  6. Chernick V., Madansky D. L., Lawson E. E. Naloxone decreases the duration of primary apnea with neonatal asphyxia. Pediatr Res. 1980 Apr;14(4 Pt 1):357–359. doi: 10.1203/00006450-198004000-00021. [DOI] [PubMed] [Google Scholar]
  7. Fleetham J. A., Clarke H., Dhingra S., Chernick V., Anthonisen N. R. Endogenous opiates and chemical control of breathing in humans. Am Rev Respir Dis. 1980 Jun;121(6):1045–1049. doi: 10.1164/arrd.1980.121.6.1045. [DOI] [PubMed] [Google Scholar]
  8. Flórez J., Mediavilla A. Respiratory and cardiovascular effects of met-enkephalin applied to the ventral surface of the brain stem. Brain Res. 1977 Dec 23;138(3):585–900. doi: 10.1016/0006-8993(77)90699-0. [DOI] [PubMed] [Google Scholar]
  9. Lawson E. E., Waldrop T. G., Eldridge F. L. Naloxone enhances respiratory output in cats. J Appl Physiol Respir Environ Exerc Physiol. 1979 Nov;47(5):1105–1111. doi: 10.1152/jappl.1979.47.5.1105. [DOI] [PubMed] [Google Scholar]
  10. Lederer D. H., Altose M. D., Kelsen S. G., Cherniack N. S. Comparison of occlusion pressure and ventilatory responses. Thorax. 1977 Apr;32(2):212–220. doi: 10.1136/thx.32.2.212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Lord J. A., Waterfield A. A., Hughes J., Kosterlitz H. W. Endogenous opioid peptides: multiple agonists and receptors. Nature. 1977 Jun 9;267(5611):495–499. doi: 10.1038/267495a0. [DOI] [PubMed] [Google Scholar]
  12. Lundberg J. M., Hökfelt T., Fahrenkrug J., Nilsson G., Terenius L. Peptides in the cat carotid body (glomus caroticum): VIP-, enkephalin-, and substance P-like immunoreactivity. Acta Physiol Scand. 1979 Nov;107(3):279–281. doi: 10.1111/j.1748-1716.1979.tb06475.x. [DOI] [PubMed] [Google Scholar]
  13. Martin W. R., Eades C. G., Thompson J. A., Huppler R. E., Gilbert P. E. The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog. J Pharmacol Exp Ther. 1976 Jun;197(3):517–532. [PubMed] [Google Scholar]
  14. Milic-Emili J., Grunstein M. M. Drive and timing components of ventilation. Chest. 1976 Jul;70(1 Suppl):131–133. doi: 10.1378/chest.70.1_supplement.131. [DOI] [PubMed] [Google Scholar]
  15. Milic-Emili J., Whitelaw W. A., Derenne J. P. New tests to assess lung function: occlusion pressure--a simple measure of the respiratory center's output. N Engl J Med. 1975 Nov 13;293(20):1029–1030. doi: 10.1056/NEJM197511132932006. [DOI] [PubMed] [Google Scholar]
  16. Moss I. R., Friedman E. beta-Endorphin: effects on respiratory regulation. Life Sci. 1978 Sep 25;23(12):1271–1276. doi: 10.1016/0024-3205(78)90505-2. [DOI] [PubMed] [Google Scholar]
  17. Moss I. R., Scarpelli E. M. beta-Endorphin central depression of respiration and circulation. J Appl Physiol Respir Environ Exerc Physiol. 1981 May;50(5):1011–1016. doi: 10.1152/jappl.1981.50.5.1011. [DOI] [PubMed] [Google Scholar]
  18. Ngai S. H., Berkowitz B. A., Yang J. C., Hempstead J., Spector S. Pharmacokinetics of naloxone in rats and in man: basis for its potency and short duration of action. Anesthesiology. 1976 May;44(5):398–401. doi: 10.1097/00000542-197605000-00008. [DOI] [PubMed] [Google Scholar]
  19. Read D. J. A clinical method for assessing the ventilatory response to carbon dioxide. Australas Ann Med. 1967 Feb;16(1):20–32. doi: 10.1111/imj.1967.16.1.20. [DOI] [PubMed] [Google Scholar]
  20. Rebuck A. S., Campbell E. J. A clinical method for assessing the ventilatory response to hypoxia. Am Rev Respir Dis. 1974 Mar;109(3):345–350. doi: 10.1164/arrd.1974.109.3.345. [DOI] [PubMed] [Google Scholar]
  21. Rebuck A. S., Woodley W. E. Ventilatory effects of hypoxia and their dependence on PCO2. J Appl Physiol. 1975 Jan;38(1):16–19. doi: 10.1152/jappl.1975.38.1.16. [DOI] [PubMed] [Google Scholar]
  22. Santiago T. V., Remolina C., Scoles V., 3rd, Edelman N. H. Endorphins and the control of breathing. Ability of naloxone to restore flow-resistive load compensation in chronic obstructive pulmonary disease. N Engl J Med. 1981 May 14;304(20):1190–1195. doi: 10.1056/NEJM198105143042002. [DOI] [PubMed] [Google Scholar]
  23. Simantov R., Kuhar M. J., Uhl G. R., Snyder S. H. Opioid peptide enkephalin: immunohistochemical mapping in rat central nervous system. Proc Natl Acad Sci U S A. 1977 May;74(5):2167–2171. doi: 10.1073/pnas.74.5.2167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Weil J. V., McCullough R. E., Kline J. S., Sodal I. E. Diminished ventilatory response to hypoxia and hypercapnia after morphine in normal man. N Engl J Med. 1975 May 22;292(21):1103–1106. doi: 10.1056/NEJM197505222922106. [DOI] [PubMed] [Google Scholar]
  25. Wharton J., Polak J. M., Pearse A. G., McGregor G. P., Bryant M. G., Bloom S. R., Emson P. C., Bisgard G. E., Will J. A. Enkephalin-, VIP- and substance P-like immunoreactivity in the carotid body. Nature. 1980 Mar 20;284(5753):269–271. doi: 10.1038/284269a0. [DOI] [PubMed] [Google Scholar]
  26. Willer J. C., Boureau F., Dauthier C., Bonora M. Study of naloxone in normal awake man: effects on heart rate and respiration. Neuropharmacology. 1979 May;18(5):469–472. doi: 10.1016/0028-3908(79)90072-8. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES